Antimicrobial activity and bioactive profiling of heterocytous cyanobacterial strains using MS/MS-based molecular networking

. 2019 Sep ; 64 (5) : 645-654. [epub] 20190805

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid31385159

Grantová podpora
LO1416 Ministerstvo Školství, Mládeže a Tělovýchovy
LM2015055 Ministerstvo Školství, Mládeže a Tělovýchovy
CZ.1.05/2.1.00/19.0392 Ministerstvo Školství, Mládeže a Tělovýchovy
CZ.02.2.69 / 0.0 / 0.0 / 18_070 / 0010493 International Mobility of Researchers - MSCA-IF II (Institute of Microbiology of the CAS, PRI) funded by Operational Programme Research, Development and Education
19-17868Y Grantová Agentura České Republiky
Cross-Border cooperation Czech-Bavaria -Project No. 41. Ministerstvo pro Místní Rozvoj České Republiky

Odkazy

PubMed 31385159
DOI 10.1007/s12223-019-00737-9
PII: 10.1007/s12223-019-00737-9
Knihovny.cz E-zdroje

The rapid emergence of resistance in pathogenic bacteria together with a steep decline in economic incentives has rendered a new wave in the drug development by the pharmaceutical industry and researchers. Since cyanobacteria are recognized as wide producers of pharmaceutically important compounds, we investigated thirty-four cyanobacterial extracts prepared by solvents of different polarities for their antimicrobial potential. Almost all tested cyanobacterial strains exhibited some degree of antimicrobial bioactivity, with more general effect on fungal strains compared with bacteria. Surprisingly ~50% of cyanobacterial extracts exhibited specific activity against one or few bacterial indicator strains with Gram-positive bacteria being more affected. Extracts of two most promising strains were subjected to activity-guided fractionation and determination of the minimum inhibitory concentration (MIC) against selected bacterial and fungal isolates. Multiple fractions were responsible for their antimicrobial effect with MIC reaching low-micromolar concentrations and in some of them high level of specificity was recorded. Twenty-six bioactive fractions analyzed on LC-HRMS/MS and Global Natural Product Social Molecular Networking (GNPS) online workflow using dereplication resulted in identification of only forty-nine peptide spectrum matches (PSMs) with eleven unique metabolites spectrum matches (MSMs). Interestingly, only three fractions from Nostoc calcicola Lukešová 3/97 and four fractions from Desmonostoc sp. Cc2 showed the presence of unique MSMs suggesting the presence of unknown antimicrobial metabolites among majority of bioactive fractions from both the strains. Our results highlight potential for isolation and discovery of potential antimicrobial bioactive lead molecules from cyanobacterial extracts.

Zobrazit více v PubMed

Ecotoxicol Environ Saf. 2016 Feb;124:177-185 PubMed

Folia Microbiol (Praha). 2006;51(3):159-82 PubMed

J Nat Prod. 2008 Jun;71(6):1095-8 PubMed

Can J Infect Dis Med Microbiol. 2005 May;16(3):159-60 PubMed

Molecules. 2018 Oct 16;23(10):null PubMed

J Clin Microbiol. 2007 Jul;45(7):2180-2 PubMed

Chembiochem. 2013 Nov 25;14(17):2329-37 PubMed

Med Res Rev. 2016 Jan;36(1):4-31 PubMed

Phytochemistry. 2012 Feb;74:173-7 PubMed

Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S43-8 PubMed

Folia Microbiol (Praha). 2018 Sep;63(5):569-579 PubMed

Nat Commun. 2018 Oct 2;9(1):4035 PubMed

Mar Drugs. 2016 May 17;14(5): PubMed

Front Microbiol. 2017 Apr 25;8:515 PubMed

Nat Chem Biol. 2017 Jan;13(1):30-37 PubMed

Trends Pharmacol Sci. 2017 Feb;38(2):143-154 PubMed

Environ Toxicol. 2011 Aug;26(4):345-58 PubMed

Nat Microbiol. 2018 Mar;3(3):319-327 PubMed

Microb Biotechnol. 2014 May;7(3):209-20 PubMed

Nat Rev Drug Discov. 2015 Feb;14(2):111-29 PubMed

Crit Rev Microbiol. 2016 May;42(3):394-405 PubMed

Appl Environ Microbiol. 2019 Feb 6;85(4): PubMed

Sci Prog. 2015;98(Pt 2):145-68 PubMed

J Proteome Res. 2008 Jan;7(1):113-22 PubMed

Curr Opin Biotechnol. 2010 Dec;21(6):787-93 PubMed

Nat Biotechnol. 2016 Aug 9;34(8):828-837 PubMed

BMC Evol Biol. 2011 Feb 14;11:45 PubMed

Front Microbiol. 2016 Apr 05;7:416 PubMed

Mar Drugs. 2017 Feb 23;15(3):null PubMed

Proc Natl Acad Sci U S A. 2011 May 24;108(21):8815-20 PubMed

Toxicon. 2018 Aug;150:66-73 PubMed

Rev Iberoam Micol. 2012 Jan-Mar;29(1):29-33 PubMed

Chem Biol. 2012 Jan 27;19(1):85-98 PubMed

Phytochem Anal. 2014 Jan-Feb;25(1):13-28 PubMed

BMC Complement Altern Med. 2017 Feb 7;17(1):99 PubMed

Bioinformatics. 2008 Nov 1;24(21):2534-6 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...